Vaxabov B.M. HYPERLIPIDEMIA-SPECIFIC BIOMARKERS WOULD IMPROVE CLINICAL DIAGNOSIS AND THERAPEUTIC TREATMENT AT EARLY DISEASE STAGES. jasass 2025, 15, 627-630.